ELAVL1 and nasopharyngeal carcinoma: In addition, miR-514a-5p inhibitor could partially counteract promoting effect of SNHG7 knockdown on NPC progression, and ELAVL1 silence reserved the effect of sh-SNHG7 + miR-514a-5p inhibitor on NPC progression.